MOOLEC SCIENCE (MLEC)
(Real Time Quote from BATS)
$1.29 USD
-0.03 (-2.27%)
Updated May 21, 2024 01:14 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
MLEC 1.29 -0.03(-2.27%)
Will MLEC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MLEC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MLEC
Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)
MLEC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLEC
Warning: MLEC is at high risk of performing badly
CYCC, BCAB and CARV among pre-market losers
Moolec Announces New Patent Granting in the United States for Molecular Farming Platform
CSSE, RVYL and RCAT among mid-day movers
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers